Clinical studies recruiting near Candiolo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Istituto Nazionale Oncologico Candiolo · Iksuda Therapeutics Ltd. · NCT05365659 Observational Study on Skeletal Ewing's Sarcoma
Phase N/A · I.R.C.C. - Unit of Medical Oncology · Italian Sarcoma Group · NCT04845893 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Phase 1 · Istituto di Candiolo Fondazione del Piemonte per l'oncologia · Valo Therapeutics Oy · NCT05492682 Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer
NA · Breast Unit · Fondazione del Piemonte per l'Oncologia · NCT07507890 Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Phase N/A · Fondazione Del Piemonte Per L'Oncologia Centro Trapianti · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT04867915 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo · Daiichi Sankyo · NCT06330064 A Global, Integrated, Personalized, Stage-related, Multimodal Therapeutic Approach for Rectal Adenocarcinoma Based on Or
NA · Department of Surgical Oncology - FPO-IRCCS Institute for Ca · Fondazione del Piemonte per l'Oncologia · NCT06952101 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Takeda · NCT06499285 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0326 · Bristol-Myers Squibb · NCT03899155 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site IT009 · Incyte Corporation · NCT07522073 Galenos 2 Immunonutrition in Head and Neck, Lung, and Rectal Cancer Patients
NA · Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di C · Fondazione del Piemonte per l'Oncologia · NCT07514754 A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors
Phase N/A · Fondazione del Piemonte per l'Oncologia · Fondazione del Piemonte per l'Oncologia · NCT07453082 Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Phase N/A · IRCCS Istituto di Candiolo Fondazione del Piemonte per l'Onc · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT07496242 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Ly
Phase N/A · Fondazione del Piemonte per l'Oncologia - IRCCS - Ematologia · Fondazione Italiana Linfomi - ETS · NCT06008691 INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations
Phase N/A · Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo · Fondazione del Piemonte per l'Oncologia · NCT06334809 Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · Istituto Di Candiolo · Boehringer Ingelheim · NCT06324357 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site IT39011 · Astellas Pharma Global Development, Inc. · NCT02960022 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · Istituto di Candiolo, IRCCS · Stemline Therapeutics, Inc. · NCT05386108 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Phase 3 · IRCCS La Fondazione e l'Istituto di Candiolo · Cogent Biosciences, Inc. · NCT05208047 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · Istituto di Candiolo Fondazione del Piemonte per l'Oncologia · AbbVie · NCT07155187 Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
NA · Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo · Fondazione del Piemonte per l'Oncologia · NCT06318559 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · INOC - Istituto Nazionale Oncologico Candiolo ( Site 1960) · Merck Sharp & Dohme LLC · NCT03486873 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · Fondazione del Piemonte per l'Oncologia IRCC Candiolo · SystImmune Inc. · NCT05983432 A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
Phase N/A · Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo · Fondazione del Piemonte per l'Oncologia · NCT07469709 Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Ly
Phase N/A · I.R.C.C.S. Istituto di Candiolo - FPO · Fondazione Italiana Linfomi - ETS · NCT06588205 Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA
Phase 1/Phase 2 · IRCCS · Groupe Francophone des Myelodysplasies · NCT05181735 Complete Mesocolic Excision in Comparison With Conventional Surgery for the Right Colon Cancer
NA · Candiolo Cancer Institute - IRCCS · University of Turin, Italy · NCT04871399 Clinical Study in Adult and Young Adult Patients With Advanced Desmoplastic Small Round Cell Tumor (DSRCT) ISG-TULIPS
Phase 2 · Fondazione del Piemonte per l'Oncologia IRCCS · Italian Sarcoma Group · NCT07328425 The Italian Registry of Malnutrition in Oncology
Phase N/A · Istituto di Candiolo - Fondazione del Piemonte per l'Oncolog · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06337019

Look up another city

Look up another condition